How NAVA Works in Preterm Infants With Irregular Respiratory Efforts

NCT04659083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18

Last updated 2021-01-12

No results posted yet for this study

Summary

For the infant participating the study, ventilator settings and respiratory variables will be recorded every day and exported to a specific computer using the Servo Record Viewer version 1.0 (Maquet Critical Care AB, Getinge, Gothenburg, Sweden). Collected data gives the value for peak inspiratory pressure (PIP), expiratory tidal volume (Vt), peak Edi, minimum Edi, measured respiratory rate (RR), neural respiratory rate (nRR) and percentage of backup breaths for each minute. All the ventilator data will be inspected and compared with the event logs recorded automatically from the ventilator, which includes all the alarm notification, mode and setting changes, cables connection and disconnection data. Data during disconnection of the Edi cable, malfunction or dislocation of Edi catheter will be excluded from the analysis. The mean values during each day will be computed for each ventilatory variables. If there is a change in the ventilatory setting parameters, we will choose the one which was applied for longer duration in the 24-hour time period.

The following clinical characteristics will be collected from medical records: gestational age at birth, birth weight, gender, the time and amount of feeding, medication during the study days, desaturation events, bradycardia events, suction time and methods.

Conditions

  • Premature Infants
  • Neurally Adjusted Ventilatory Assist
  • Ventilator Lung; Newborn
  • Mechanical Ventilation

Interventions

DEVICE

Neurally adjusted ventilatory assist ventilation mode

This technique uses the electrical activity of the diaphragm (Edi) to control respiratory support and the NAVA level as an amplification factor that converts the Edi signal into a proportional pressure.

Sponsors & Collaborators

  • Turku University Hospital

    collaborator OTHER_GOV
  • Inha University Hospital

    lead OTHER

Eligibility

Min Age
0 Days
Max Age
36 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-12-31
Completion
2020-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04659083 on ClinicalTrials.gov